The UK government has confirmed that health data from UK Biobank, affecting 500,000 people, was listed for sale in China. According to the official statement, the data involved medical information, but no personally identifiable information was made available.
UK Biobank is a major health research resource, and the scale of the incident has raised fresh questions about data security and international exposure of sensitive medical datasets. Early coverage suggests the government sought to reassure the public by emphasizing that identifying details were not included in what was listed.
What the government said
The government said the affected dataset related to 500,000 people. While the listing has prompted concern due to the sensitivity of health information, officials stated that no personally identifiable information had been exposed through the material made available.
Why the case matters
The case is likely to intensify scrutiny of how large-scale health datasets are stored, shared and protected. Reports indicate the incident will add to wider debates about medical data governance, research access and the safeguards needed when handling information tied to public health and scientific studies.